CAGNAZZO, Celeste
CAGNAZZO, Celeste
SCIENZE DELLA SANITA' PUBBLICA E PEDIATRICHE
A multitarget lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2
2021-01-01 Simone Cavalera; Barbara Colitti; Sergio Rosati; Gianmarco Ferrara; Luigi Bertolotti; Chiara Nogarol; Cristina Guiotto; Celeste Cagnazzo; Marco Denina; Franca Fagioli; Fabio Di Nardo; Matteo Chiarello; Claudio Baggiani; Laura Anfossi
A phase I dose-escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer.
2014-01-01 Aglietta M;Barone C;Sawyer MB;Moore MJ;Miller WH Jr;Bagalà C;Colombi F;Cagnazzo C;Gioeni L;Wang E;Huang B;Fly KD;Leone F
Adoptive immunotherapy against ovarian cancer
2016-01-01 Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio
Bacterial ligands as flexible and sensitive detectors in rapid tests for antibodies to SARS-CoV-2
2022-01-01 Simone Cavalera; Fabio Di Nardo; Matteo Chiarello; Thea Serra; Barbara Colitti; Cristina Guiotto; Franca Fagioli; Celeste Cagnazzo; Marco Denina; Annagloria Palazzo; Fiora Artusio; Roberto Pisano; Sergio Rosati; Claudio Baggiani; Laura Anfossi
Biliary tract carcinomas: From chemotherapy to targeted therapy.
2013-01-01 Marino D; Leone F; Cavalloni G; Cagnazzo C; Aglietta M.
Bureaucracy gives way to science. What good the pandemic has left
2020-01-01 Cagnazzo C.; Fagioli F.
Clinical research and burnout syndrome in Italy – only a physicians’ affair?
2021-01-01 Cagnazzo, Celeste; Filippi, Roberto; Zucchetti, Giulia; Cenna, Rosita; Taverniti, Cristiana; Guarrera, Agata Sue Ellen; Stabile, Stefano; Federici, Irene; Monti, Manuela; Pirondi, Sara; Testoni, Sara; Fagioli, Franca
Clinical research coordinators: A crucial resource
2019-01-01 Cagnazzo C.; Testoni S.; Guarrera A.S.; Stabile S.; Taverniti C.; Federici I.; Pirondi S.; Monti M.
Clinical research nurse in Italian centers: A mandatory figure?
2020-01-01 Martucci M.; Guarrera A.; Valente D.; Resente F.; Cagnazzo C.
Clinical research: Enough players to get out there?
2019-01-01 Cagnazzo C.; Guarrera A.; Cenna R.; Taverniti C.; Stabile S.; Federici I.; Pirondi S.; Testoni S.; Monti M.
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer.
2018-01-01 Gobbini, Elisa; Pilotto, S; Pasello, G; Polo, V; Di Maio, M; Arizio, F; Galetta, D; Petrillo, P; Chiari, R; Matocci, R; Di Costanzo, A; Di Stefano Ts, ; Aglietta, Massimo; Cagnazzo, C; Sperduti, I; Bria, Emilio; Novello, Silvia
Fluoropyrimidine-induced cardiotoxicity
2018-01-01 Depetris, Ilaria; Marino, Donatella; Bonzano, Alessandro; Cagnazzo, Celeste; Filippi, Roberto; Aglietta, Massimo; Leone, Francesco
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience
2017-01-01 Marchesi, Emanuela; Cagnazzo, Celeste; Quattrini, Irene; Leopardi, Martina Piccinni; Villa, Chiara; Grignani, Giovanni; D'Ambrosio, Lorenzo; Stacchiotti, Silvia; Casali, Paolo Giovanni; Picci, Piero
Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution Experience
2019-01-01 Fenocchio, Elisabetta; Colombi, Federica; Calella, Maria Grazia; Filippi, Roberto; Depetris, Ilaria; Chilà, Giovanna; Lombardi, Pasquale; Marino, Donatella; Cagnazzo, Celeste; Ferraris, Renato; Vaira, Marco; Aglietta, Massimo; Leone, Francesco
Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in Italy
2020-01-01 Pinto C.; Cagnazzo C.
Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?
2021-01-01 Cagnazzo C.; Besse M.-G.; Manfellotto D.; Minghetti P.; Cazzaniga S.; Cottini L.; Fontanella A.; Maruti I.; Stabile S.; Testoni S.; Trogu P.; Sinno V.; Gussoni G.
New european clinical trial regulation: Perception and expectations in italy
2017-01-01 Cagnazzo C.; Campora S.; Ferretti E.; Arizio F.; Marchesi E.
New requirements for phase i trials: A challenge for I talian clinical research
2018-01-01 Marchesi E.; Monti M.; Nanni O.; Bassi L.; Piccinni-Leopardi M.; Cagnazzo C.
Off-label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center
2023-01-01 Cenna, Rosita; Basiricò, Marco; Berchialla, Paola; Bertorello, Nicoletta; Cagnazzo, Celeste; Ceolin, Valeria; De Luna, Elvira; Nolis, Chiara; Resente, Francesca; Fagioli, Franca
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study)
2016-01-01 Leone, Francesco; Marino, Donatella; Cereda, Stefano; Filippi, Roberto; Belli, Carmen; Spadi, Rosella; Nasti, Guglielmo; Montano, Massimo; Amatu, Alessio; Aprile, Giuseppe; Cagnazzo, Celeste; Fasola, Gianpiero; Siena, Salvatore; Ciuffreda, Libero; Reni, Michele; Aglietta, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A multitarget lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2 | 2021 | Simone Cavalera; Barbara Colitti; Sergio Rosati; Gianmarco Ferrara; Luigi Bertolotti; Chiara Nogarol; Cristina Guiotto; Celeste Cagnazzo; Marco Denina; Franca Fagioli; Fabio Di Nardo; Matteo Chiarello; Claudio Baggiani; Laura Anfossi | |
| A phase I dose-escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer. | 2014 | Aglietta M;Barone C;Sawyer MB;Moore MJ;Miller WH Jr;Bagalà C;Colombi F;Cagnazzo C;Gioeni L;Wang E;Huang B;Fly KD;Leone F | |
| Adoptive immunotherapy against ovarian cancer | 2016 | Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio | |
| Bacterial ligands as flexible and sensitive detectors in rapid tests for antibodies to SARS-CoV-2 | 2022 | Simone Cavalera; Fabio Di Nardo; Matteo Chiarello; Thea Serra; Barbara Colitti; Cristina Guiotto; Franca Fagioli; Celeste Cagnazzo; Marco Denina; Annagloria Palazzo; Fiora Artusio; Roberto Pisano; Sergio Rosati; Claudio Baggiani; Laura Anfossi | |
| Biliary tract carcinomas: From chemotherapy to targeted therapy. | 2013 | Marino D; Leone F; Cavalloni G; Cagnazzo C; Aglietta M. | |
| Bureaucracy gives way to science. What good the pandemic has left | 2020 | Cagnazzo C.; Fagioli F. | |
| Clinical research and burnout syndrome in Italy – only a physicians’ affair? | 2021 | Cagnazzo, Celeste; Filippi, Roberto; Zucchetti, Giulia; Cenna, Rosita; Taverniti, Cristiana; Guarrera, Agata Sue Ellen; Stabile, Stefano; Federici, Irene; Monti, Manuela; Pirondi, Sara; Testoni, Sara; Fagioli, Franca | |
| Clinical research coordinators: A crucial resource | 2019 | Cagnazzo C.; Testoni S.; Guarrera A.S.; Stabile S.; Taverniti C.; Federici I.; Pirondi S.; Monti M. | |
| Clinical research nurse in Italian centers: A mandatory figure? | 2020 | Martucci M.; Guarrera A.; Valente D.; Resente F.; Cagnazzo C. | |
| Clinical research: Enough players to get out there? | 2019 | Cagnazzo C.; Guarrera A.; Cenna R.; Taverniti C.; Stabile S.; Federici I.; Pirondi S.; Testoni S.; Monti M. | |
| Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. | 2018 | Gobbini, Elisa; Pilotto, S; Pasello, G; Polo, V; Di Maio, M; Arizio, F; Galetta, D; Petrillo, P; Chiari, R; Matocci, R; Di Costanzo, A; Di Stefano Ts, ; Aglietta, Massimo; Cagnazzo, C; Sperduti, I; Bria, Emilio; Novello, Silvia | |
| Fluoropyrimidine-induced cardiotoxicity | 2018 | Depetris, Ilaria; Marino, Donatella; Bonzano, Alessandro; Cagnazzo, Celeste; Filippi, Roberto; Aglietta, Massimo; Leone, Francesco | |
| How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience | 2017 | Marchesi, Emanuela; Cagnazzo, Celeste; Quattrini, Irene; Leopardi, Martina Piccinni; Villa, Chiara; Grignani, Giovanni; D'Ambrosio, Lorenzo; Stacchiotti, Silvia; Casali, Paolo Giovanni; Picci, Piero | |
| Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution Experience | 2019 | Fenocchio, Elisabetta; Colombi, Federica; Calella, Maria Grazia; Filippi, Roberto; Depetris, Ilaria; Chilà, Giovanna; Lombardi, Pasquale; Marino, Donatella; Cagnazzo, Celeste; Ferraris, Renato; Vaira, Marco; Aglietta, Massimo; Leone, Francesco | |
| Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in Italy | 2020 | Pinto C.; Cagnazzo C. | |
| Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future? | 2021 | Cagnazzo C.; Besse M.-G.; Manfellotto D.; Minghetti P.; Cazzaniga S.; Cottini L.; Fontanella A.; Maruti I.; Stabile S.; Testoni S.; Trogu P.; Sinno V.; Gussoni G. | |
| New european clinical trial regulation: Perception and expectations in italy | 2017 | Cagnazzo C.; Campora S.; Ferretti E.; Arizio F.; Marchesi E. | |
| New requirements for phase i trials: A challenge for I talian clinical research | 2018 | Marchesi E.; Monti M.; Nanni O.; Bassi L.; Piccinni-Leopardi M.; Cagnazzo C. | |
| Off-label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center | 2023 | Cenna, Rosita; Basiricò, Marco; Berchialla, Paola; Bertorello, Nicoletta; Cagnazzo, Celeste; Ceolin, Valeria; De Luna, Elvira; Nolis, Chiara; Resente, Francesca; Fagioli, Franca | |
| Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study) | 2016 | Leone, Francesco; Marino, Donatella; Cereda, Stefano; Filippi, Roberto; Belli, Carmen; Spadi, Rosella; Nasti, Guglielmo; Montano, Massimo; Amatu, Alessio; Aprile, Giuseppe; Cagnazzo, Celeste; Fasola, Gianpiero; Siena, Salvatore; Ciuffreda, Libero; Reni, Michele; Aglietta, Massimo |